Bright Peak Therapeutics Email Format

Biotechnology ResearchBasel-stadt, Switzerland11-50 Employees

Bright Peak Therapeutics is a biotechnology company focused on developing cytokine-based therapies for cancer and autoimmune diseases. It designs first-in-class and best-in-class cytokines that can be conjugated to antibodies to create Bright Peak Immunocytokines, as well as to other cytokines to form duokines. Using a site-specific conjugation approach, it enables tissue- and cell-specific delivery of cytokine payloads and offers an off-the-shelf option that avoids extensive antibody engineering. Based in Basel, with a presence in Southern California, the organization operates as a small to mid-sized, international research-driven biotech company. In April 2025, Bright Peak announced the appointment of John Schmid to its board of directors.

Sign up for free to view info

Company overview Employee directory